We have previously reported that seminal plasma from HIV negative men can markedly enhance HIV infection of permissive cells, and that this activity is positively associated with endogenous concentrations of SEM1(86-107), a peptide derived from a protein produced by the seminal vesicles. In vitro, SEM1(86-107) polymerizes to form amyloid fibrils that enhance HIV infection, and endogenous SEM1(86-107) amyloid aggregates can be detected in semen. We hypothesized that in HIV-infected individuals, semen factors that promote HIV infection might also increase the semen HIV viral load.
We examined the relationships among semen viral load, HIV infection enhancing activity, and inflammatory cytokines in semen samples from 122 HIV-infected individuals. Samples were obtained at least 4 months post seroconversion; 149 specimens were obtained from 103 ART naïve donors, 20 donated pre-and post-ART suppression, and 20 pre-and post-interruption of ART. HIV infection of TZM-bl cells in the presence vs. absence of semen was used to quantitate viral enhancing activity. Inflammatory cytokines and chemokines were measured by Luminex in semen and blood.
The degree to which semen enhanced HIV infection varied (from no enhancement to 30-fold) between HIV-infected individuals but was stable over time within individuals. Higher infectivity enhancement of semen was strongly correlated with the concentration of SEM1(86-107) in HIV-infected men (r=0.70, p<0.0001). In multivariate analyses controlling for the blood viral load, higher semen viral load was independently associated with higher semen infectivity enhancing activity (p=0.02) as well as with higher levels of IL8 (p=0.01) and IL6 (p=0.01). Mean IL8 levels were 245-fold higher and mean IL6 levels 25-fold higher in semen than in blood. In longitudinal experiments with patients initiating and interrupting ART, we found that changes in semen viral load with ART use did not substantially alter levels of infectivity enhancement, SEM1(86-107), or pro-inflammatory cytokines in semen.
The composition of semen can differ greatly between HIV-infected men. Some of the factors that vary between men, such as infection-enhancing amyloids and certain proinflammatory cytokines, may facilitate HIV transmission in two ways-by promoting local viral replication in the genital tract (increasing semen viral load), and/or by enhancing infection of mucosal target cells.